NISC-6 is a novel dual Topo-IIalpha/Akt inhibitor. NISC-6 has inhibitory activity against various cells, such as UACC903 (IC50 = 2.5 µM) and CHL-1 (IC50 = 0.8 µM) cells. NISC-6 dose dependently induces early and late apoptosis. NISC-6 can be used for research on melanoma[1].
Molekulargewicht:
385.32
CAS Nummer:
[2097636-49-0]
Formel:
C19H18N2O2Se
Target-Kategorie:
Akt,Apoptosis,Topoisomerase
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
